Share

Autism Spectrum Program of Excellence at UPenn (ASPE)

Study Flyer:
Eligibility Criteria:
WHO:

Researchers: Dr. Daniel J. Rader, Dr. Edward S. Brodkin
Institution:: University of Pennsylvania Learn more

WHAT:

Online surveys for adults and those with NRXN1

WHERE:

Online via Redcap

INTERESTED?

Contact:
aspe@pennmedicine.upenn.edu

Ends July 4, 2026

Study flyer:

What's the study about?

Join the Autism Spectrum Program of Excellence (ASPE) at The University of Pennsylvania in better understanding the biological processes of autism to inform support programs, increase acceptance and advocacy, and improve the quality of life for autistic individuals.

Who can participate?

ASPE is actively recruiting:

  • Individuals with an autism diagnosis or suspected autism diagnosis
  • Individuals with a Chromosome 2p16.3 deletion / NRXN1 gene deletion and their family members
  • People who are not on the autism spectrum (no diagnosis and no suspected diagnosis) to act as our control (comparison) group.

 

What will participants be doing?

Participation includes:

  • Completing a series of online questionnaires
  • Returning a free saliva kit for DNA analysis  -Option to wear a research-grade (Fitbit-like) device to track activity and sleep  -All completed in the comfort of your own home!

 

Why is this important?

Our goal is that your participation informs current and future support programs to improve the quality of life of autistic individuals. There are no direct benefits to participating in the ASPE Study.